Trial intelligence / Profile preview

Almorexant and ethanol interaction crossover study in healthy volunteers

NL-OMON32705Active, not recruiting

Sponsor
Actelion Pharmaceuticals Ltd
Start
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of almorexant and ethanol in Insomnia (4 arms), sponsored by Actelion Pharmaceuticals Ltd. Primary endpoints: Saccadic eye movements, Smooth pursuit eye movements and 8 more. Started Feb 2009; status: active, not recruiting.

02

Drugs

almorexantethanol
03

Conditions

Insomnia

Beyond the preview

Go deeper on NL-OMON32705.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32705.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call